top of page

Recent Posts

Child Cancer Survival Imperiled by Lack of New Drugs

Feb 20, 2013

1 min read

Improving childhood cancer survival rates is being stymied by regulatory burdens and stagnant research approaches, U.S. and European doctors said.

Read more here.

Trial provides first look at long-term outcomes of childhood immunotherapies

“Lower-Risk” Childhood Cancer May Be More Dangerous Than It Appears

Largest study supports three courses of radiation for children with deadly brain tumor

Unraveling how a deadly childhood cancer spreads could keep it in its place

Unraveling how immune aging influences health outcomes for survivors of childhood blood cancers

Unexpected discovery points to a possible route for childhood brain tumor treatments

Turning Pediatric Cancer Discoveries Into Medicines Requires Better Connections

Removing immune 'brake' improves CAR T-cell therapy for pediatric bone cancer

Cardiometabolic Risk in Childhood Cancer Survivors Treated With Anthracyclines

Hodgkin Lymphoma Survivors Face Higher Long-Term Mortality

Archive

Search By Tags

bottom of page